新的CAR T细胞疗法显示出有前途, New CAR T cell therapy shows promise, shrinking tumors in 12 of 18 glioblastoma patients.

新的CAR T细胞疗法显示,在治疗具有攻击性的脑癌血浆瘤方面很有前途。 A new CAR T cell therapy shows promise in treating aggressive brain cancer glioblastoma. 在与18名病人进行的一项试验中,肿瘤在近三分之二的病例中呈下降趋势,一些病人生活在一年以上,患有稳定疾病。 In a trial with 18 patients, tumors shrank in nearly two-thirds of cases, with some patients living over a year with stable disease. 该疗法针对脑肿瘤中的两种蛋白质,通过脑脊髓液注射提供,旨在通过正在进行的研究进一步提高结果。 The therapy, which targets two proteins in brain tumors and is delivered via cerebrospinal fluid injection, aims to improve outcomes further through ongoing research.